ÃÅÏÀÒÈÒ Ñ ÏÐÈ ÈÍÔÈÖÈÐÎÂÀÍÈÈ ÐÅÊÎÌÁÈÍÀÍÒÍÎÉ ÔÎÐÌÎÉ ÂÈÐÓÑÀ RF2k/1b: ÒÅ×ÅÍÈÅ È ÒÅÐÀÏÈß

Intergenotype recombinant RF2k/1b of hepatitis C virus was fi rstly detected in 2002 in the Russian Federation. In our study patients, infected with this recombinant, had high indices of liver fi brosis and did not achieve a sustained viral response to standard double therapy with exception of one participant. There are discussed and proposed options for treatment and diagnosis of these patients.